KIAA0101 (OEACT-1), an expressionally down-regulated and growth-inhibitory gene in human hepatocellular carcinoma

BMC Cancer

Volumn 6, Issue , 2006, Pages

  Guo, Minglei ^a,b   Li, Jinjun ^b,c   Wan, Dafang ^b,c   Gu, Jianren ^a,b,c  

^a FUDAN UNIVERSITY   (China)

^b SHANGHAI CANCER INSTITUTE   (China)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; MITOCHONDRIAL PROTEIN; ONCOPROTEIN;

ARTICLE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL GROWTH; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DOWN REGULATION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LIVER CELL CARCINOMA; MITOCHONDRION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; TISSUE DISTRIBUTION; WESTERN BLOTTING;

ANTIBODIES; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CARRIER PROTEINS; CELL CYCLE; DOWN-REGULATION; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 33745642692     PISSN: 14712407     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-6-109     Document Type: Article

References (11)

1. Li D, Cao Y, He L, Wang NJ, Gu JR: Aberrations of p53 gene in human hepatocellular carcinoma from China. Carcinogenesis 1993, 14(2):169-173.
2. Qin LF, Ng IO, Fan ST, Ng M: P21/WAF1, P53 and PCNA expression and P53 mutation status in hepatocellular carcinoma. Int J Cancer 1998, 79(4):424-428.
3. Tannapfel A, Grund D, Katalinic A, Uhlmann D, Kockerling F, Haugwitz U, Wasner M, Hauss J, Engeland K, Wittekind C: Decreased expression of p27 protein is associated with advanced tumor stage in hepatocellular carcinoma. Int J Cancer 2000, 89(4):350-355.
4. Wong CM, Fan ST, Ng IO: β-catenin mutation and overexpression in hepatocellular carcinoma. Cancer 2001, 92(1):136-145.
5. Yao YJ, Ping XL, Zhang H, Chen FF, Lee PK, Ahsan H, Chen CJ, Lee PH, Peacocke M, Santella RM, Tsou HC: PTEN/MMAC1 mutations in hepatocellular carcinomas. Oncogene 1999, 18(20):3181-3185.
6. Xu Liang, Hui Lijian, Wang Shaohui, Gong Jialei, Jin Ying, Wang Yanping, Ji Yuan, Wu Xin, Han Zheguang, Hu Gengxi: Expression Profiling Suggested a Regulatory Role of Liver-enriched Transcription Factors in Human Hepatocellular Carcinoma1. Cancer Res 2001, 61(7):3176-3181.
7. Mizutani K, Onda M, Asaka S, Akaishi J, Miyamoto S, Yoshida A, Nagahama M, Ito K, Emi M: Overexpressed in anaplastic thyroid carcinoma-1 (OEATC-1) as a novel gene responsible for anaplastic thyroid carcinoma. Cancer 2005, 103(9):1785-90.
8. Petroziello Joseph, Yamane Andrew, Westendorf Lori, Thompson Melissa, McDonagh Charlotte, Cerveny Charles, Law Che-Leung, Wah Alan, Paul Carter: Suppression subtractive hybridization and expression profiling identifies a unique set of genes overexpressed in non-small-cell lung cancer. Oncogene 2004, 23(46):7734-7745.
9. Simpson F, Lammerts van Bueren K, Butterfield N, Bennetts JS, Bowles J, Adolphe C, Simms LA, Young J, Walsh MD, Leggett B, Fowles LF, Wicking C: The PCNA-associated factor KIAA0101/p15(PAF) binds the potential tumor suppressor product p33ING1b. Exp Cell Res 2006, 312(1):73-85.
10. Notterman DA, Alon U, Sierk AJ, Levine AJ: transcriptional gene expression profiles of colorectal adenoma, adenocarcinoma, and normal tissue examined by oligonucleotide arrays. Cancer Res 2001, 61(7):3124-3130.
11. Chen G, Gharib TG, Huang CC, Tylors JMG, Misek DE, Kardia SLR, Giordano TJ, Iannettoni MD, Orringer MB, Hanash SM, Beer DG: discordant protein and mRNA expression in lung adenocarcinaomas. Molecular & cellular Proteomics 2002, 1:304-313.